Skip to main content

The GOING study: Regorafenib followed by Nivolumab in patients with Hepatocellular Carcinoma progressing under sorafenib

Open
  • Protocol code: GOING
  • EudraCT code: 2019-003108-10
  • Research group: Liver Diseases
  • Service: Hepatology
  • Principal investigator:  Minguez Rosique, Beatriz
  • Phase: Fase I
  • Status: Recruiting volunteers